Findings from Boehringer Ingelheim’s recent rollout of AI in Pharmacovigilance (PV)
What was the opportunity? Claudia Lehman, Boehringer Ingelheim (CL): We had already seen considerable
What was the opportunity? Claudia Lehman, Boehringer Ingelheim (CL): We had already seen considerable
Introduction: Background and Significance of PACAP With the massive success of Semaglutide and related
Peptides and oligonucleotides (TIDES) are transforming modern medicine by precisely targeting disease pathways, expanding
Negativity. Sadly, that seems to be the single word to describe the popular view
Introduction Pharmaceutical, Biotech, and MedTech companies operate globally with complex portfolios and diverse production
Introduction and general definition At first, it should not be forgotten that similar fabrication
Navigating the complexities of pressurized metered-dose inhalers (pMDIs) in a rapidly changing market presents
This article examines the critical importance of sustainable and scalable sample storage in safeguarding R&D samples for pharmaceutical, biotech, and CDMO organizations. It highlights how overlooked storage risks — from outdated infrastructure to regulatory gaps and transport failures — can compromise sample viability, delay research timelines, and drive up costs. The article aims to show that integrated sample stability and biorepository management should be proactive, requiring robust systems, smart cold chain logistics, disaster recovery planning, and clear data traceability. By reassessing internal capabilities and strategically outsourcing when appropriate, companies can protect their research investments and ensure continued innovation and compliance.
Proteolysis-targeting chimeras (PROTACs) hold considerable potential for the treatment of diseases such as cancer. Following their first publication in 2001, their development has rapidly progressed, with some now reaching Phase III trials. However, developing PROTACs successfully requires a robust, multidisciplinary framework, especially during pre-formulation and analytical development.
This article examines the basic mechanisms and characteristics of PROTACs, highlighting the importance of early-phase formulation decisions during development. Additionally, solid form and solubility strategies for maximizing ease of formulation, including particle engineering and amorphous solid dispersions (ASDs), are also explored. Finally, the article highlights the vital role of contract development and manufacturing organizations (CDMOs) in leveraging handling capabilities and technical know-how to help innovators unlock the full potential of these novel molecules.
Spray Freeze Drying can provide significant improvements to processing in pharmaceuticals and has wide applicability in a diverse array of fields. Yet the process is still relatively new and further understanding will yield additional value.
Recent technological advances in artificial intelligence and machine learning have led to a rise in software platforms that automate many of the model building and visualization tasks. These tools allow scientists to both interpret existing data, make predictions, and identify next best experiments in a cost effective and accessible manner. This accessibility allows trained scientists, even without data science or coding experience, to extract knowledge from datasets and accelerate R&D through targeted experimentation.
In this study, different types of data were assembled from experiments using a wide range of materials and process conditions. A cloud-based platform that combines exploratory data analysis, machine learning modeling, and experiment planning using Bayesian optimization was selected to perform an initial analysis and suggest further work. The results using the Sunthetics platform to derive insight into the dynamic freeze drying step of spray freeze drying processes are discussed.